Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

Jyoti Mehrotra, Shobha Varde, Haiying Wang, Hsiling Chiu, Janet Vargo, Karen Gray, Raymond B Nagle, Jaclyn R. Neri, Abhijit Mazumder

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

BACKGROUND. Although a field effect in which transformed cells extend beyond morphologically evident tumor has been proposed in cancer, little direct evidence exists as to its magnitude and spatial resolution. We tested this hypothesis using molecular techniques to detect epigenetic changes in the primary tumor and surrounding tissues. METHODS. Ex vivo core biopsies, each spaced approximately 1 mm apart, were generated from 37 unique prostatectomy samples. The first core biopsy was confirmed to be histologically positive for cancer, and the subsequent biopsies were confirmed to be histologically negative. The methylation ratio of GSTPl, APC, RARβ2, and RASSF1A were measured for all of the 159 cores. RESULTS. No field effect, defined as absence of epigenetically transformed cells, for GSTP1 was observed whereas APC, RARβ2, and RASSF1A showed a field effect up to 3 mm from the malignant core in three prostatectomy samples. Furthermore, for each case, different patterns of the field effect were observed. The field effect appeared most pronounced with RARβ2. In 11 prostatectomy samples in which a second focus of cancer was identified, cells harboring RARβ2 methylation extended a large distance away from the primary tumor in one sample. Bisulfite sequencing of RARβ2 confirmed the presence of epigenetic aberrations. CONCLUSIONS. This study quantifies previous observations of methylation in histologically negative samples and provides important assessment of field effects based on epigenetic events in cancer. These molecular approaches set the stage for consideration of such data in prospective trials for assessment of surgical margins and prediction of recurrence.

Original languageEnglish (US)
Pages (from-to)152-160
Number of pages9
JournalProstate
Volume68
Issue number2
DOIs
StatePublished - Feb 1 2008

Fingerprint

Epigenomics
Prostatic Neoplasms
Prostatectomy
Methylation
Neoplasms
Biopsy
Second Primary Neoplasms
Recurrence

Keywords

  • Field effect
  • GSTP1
  • Methylation

ASJC Scopus subject areas

  • Urology

Cite this

Mehrotra, J., Varde, S., Wang, H., Chiu, H., Vargo, J., Gray, K., ... Mazumder, A. (2008). Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. Prostate, 68(2), 152-160. https://doi.org/10.1002/pros.20675

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. / Mehrotra, Jyoti; Varde, Shobha; Wang, Haiying; Chiu, Hsiling; Vargo, Janet; Gray, Karen; Nagle, Raymond B; Neri, Jaclyn R.; Mazumder, Abhijit.

In: Prostate, Vol. 68, No. 2, 01.02.2008, p. 152-160.

Research output: Contribution to journalArticle

Mehrotra, J, Varde, S, Wang, H, Chiu, H, Vargo, J, Gray, K, Nagle, RB, Neri, JR & Mazumder, A 2008, 'Quantitative, spatial resolution of the epigenetic field effect in prostate cancer', Prostate, vol. 68, no. 2, pp. 152-160. https://doi.org/10.1002/pros.20675
Mehrotra J, Varde S, Wang H, Chiu H, Vargo J, Gray K et al. Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. Prostate. 2008 Feb 1;68(2):152-160. https://doi.org/10.1002/pros.20675
Mehrotra, Jyoti ; Varde, Shobha ; Wang, Haiying ; Chiu, Hsiling ; Vargo, Janet ; Gray, Karen ; Nagle, Raymond B ; Neri, Jaclyn R. ; Mazumder, Abhijit. / Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. In: Prostate. 2008 ; Vol. 68, No. 2. pp. 152-160.
@article{1fbdbe6d85a94a7a8609711f348a2969,
title = "Quantitative, spatial resolution of the epigenetic field effect in prostate cancer",
abstract = "BACKGROUND. Although a field effect in which transformed cells extend beyond morphologically evident tumor has been proposed in cancer, little direct evidence exists as to its magnitude and spatial resolution. We tested this hypothesis using molecular techniques to detect epigenetic changes in the primary tumor and surrounding tissues. METHODS. Ex vivo core biopsies, each spaced approximately 1 mm apart, were generated from 37 unique prostatectomy samples. The first core biopsy was confirmed to be histologically positive for cancer, and the subsequent biopsies were confirmed to be histologically negative. The methylation ratio of GSTPl, APC, RARβ2, and RASSF1A were measured for all of the 159 cores. RESULTS. No field effect, defined as absence of epigenetically transformed cells, for GSTP1 was observed whereas APC, RARβ2, and RASSF1A showed a field effect up to 3 mm from the malignant core in three prostatectomy samples. Furthermore, for each case, different patterns of the field effect were observed. The field effect appeared most pronounced with RARβ2. In 11 prostatectomy samples in which a second focus of cancer was identified, cells harboring RARβ2 methylation extended a large distance away from the primary tumor in one sample. Bisulfite sequencing of RARβ2 confirmed the presence of epigenetic aberrations. CONCLUSIONS. This study quantifies previous observations of methylation in histologically negative samples and provides important assessment of field effects based on epigenetic events in cancer. These molecular approaches set the stage for consideration of such data in prospective trials for assessment of surgical margins and prediction of recurrence.",
keywords = "Field effect, GSTP1, Methylation",
author = "Jyoti Mehrotra and Shobha Varde and Haiying Wang and Hsiling Chiu and Janet Vargo and Karen Gray and Nagle, {Raymond B} and Neri, {Jaclyn R.} and Abhijit Mazumder",
year = "2008",
month = "2",
day = "1",
doi = "10.1002/pros.20675",
language = "English (US)",
volume = "68",
pages = "152--160",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

AU - Mehrotra, Jyoti

AU - Varde, Shobha

AU - Wang, Haiying

AU - Chiu, Hsiling

AU - Vargo, Janet

AU - Gray, Karen

AU - Nagle, Raymond B

AU - Neri, Jaclyn R.

AU - Mazumder, Abhijit

PY - 2008/2/1

Y1 - 2008/2/1

N2 - BACKGROUND. Although a field effect in which transformed cells extend beyond morphologically evident tumor has been proposed in cancer, little direct evidence exists as to its magnitude and spatial resolution. We tested this hypothesis using molecular techniques to detect epigenetic changes in the primary tumor and surrounding tissues. METHODS. Ex vivo core biopsies, each spaced approximately 1 mm apart, were generated from 37 unique prostatectomy samples. The first core biopsy was confirmed to be histologically positive for cancer, and the subsequent biopsies were confirmed to be histologically negative. The methylation ratio of GSTPl, APC, RARβ2, and RASSF1A were measured for all of the 159 cores. RESULTS. No field effect, defined as absence of epigenetically transformed cells, for GSTP1 was observed whereas APC, RARβ2, and RASSF1A showed a field effect up to 3 mm from the malignant core in three prostatectomy samples. Furthermore, for each case, different patterns of the field effect were observed. The field effect appeared most pronounced with RARβ2. In 11 prostatectomy samples in which a second focus of cancer was identified, cells harboring RARβ2 methylation extended a large distance away from the primary tumor in one sample. Bisulfite sequencing of RARβ2 confirmed the presence of epigenetic aberrations. CONCLUSIONS. This study quantifies previous observations of methylation in histologically negative samples and provides important assessment of field effects based on epigenetic events in cancer. These molecular approaches set the stage for consideration of such data in prospective trials for assessment of surgical margins and prediction of recurrence.

AB - BACKGROUND. Although a field effect in which transformed cells extend beyond morphologically evident tumor has been proposed in cancer, little direct evidence exists as to its magnitude and spatial resolution. We tested this hypothesis using molecular techniques to detect epigenetic changes in the primary tumor and surrounding tissues. METHODS. Ex vivo core biopsies, each spaced approximately 1 mm apart, were generated from 37 unique prostatectomy samples. The first core biopsy was confirmed to be histologically positive for cancer, and the subsequent biopsies were confirmed to be histologically negative. The methylation ratio of GSTPl, APC, RARβ2, and RASSF1A were measured for all of the 159 cores. RESULTS. No field effect, defined as absence of epigenetically transformed cells, for GSTP1 was observed whereas APC, RARβ2, and RASSF1A showed a field effect up to 3 mm from the malignant core in three prostatectomy samples. Furthermore, for each case, different patterns of the field effect were observed. The field effect appeared most pronounced with RARβ2. In 11 prostatectomy samples in which a second focus of cancer was identified, cells harboring RARβ2 methylation extended a large distance away from the primary tumor in one sample. Bisulfite sequencing of RARβ2 confirmed the presence of epigenetic aberrations. CONCLUSIONS. This study quantifies previous observations of methylation in histologically negative samples and provides important assessment of field effects based on epigenetic events in cancer. These molecular approaches set the stage for consideration of such data in prospective trials for assessment of surgical margins and prediction of recurrence.

KW - Field effect

KW - GSTP1

KW - Methylation

UR - http://www.scopus.com/inward/record.url?scp=38749108119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749108119&partnerID=8YFLogxK

U2 - 10.1002/pros.20675

DO - 10.1002/pros.20675

M3 - Article

C2 - 18058812

AN - SCOPUS:38749108119

VL - 68

SP - 152

EP - 160

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 2

ER -